6-K ·Filed Sep 2, 2026

SNN

SMITH & NEPHEW PLC
NEUTRAL
Impact 2/10
Horizonmonths Processed1mo ago SEC0001654954-26-008075
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine governance filing with no trading implications. Monitor the 2026 Annual Report for narrative disclosures on shareholder feedback, but no near-term catalyst for SNN.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+20d ⚠ clustered
SNN ▼ -7.26% at T+20d
NEUTRAL call ✗ call lost -7.26% · α vs SPY -7.10% · entry $28.66 → $26.58
Next anchor: T+60d in 8w
Entry anchored
Sep 2, 07:48 AM ET
via 1-min bar
T+1d
+0.10%
call +0.10% · α -0.94%
$28.69
settled 29d ago
T+5d
-3.63%
call -3.63% · α -2.67%
$27.62
settled 22d ago
T+20d
-7.26%
call -7.26% · α -7.10%
$26.58
settled yesterday
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

Smith & Nephew filed a 6-K concluding its shareholder consultation on the 2026 Directors' Remuneration Policy and Performance Share Plan, which received less than 80% support at the May 2026 AGM. The Board adopted the plans as originally approved and granted CEO Deepak Nath top-up awards: a PSP award of 323,728 shares (350% of salary) and an RSP award of 23,123 shares (25% of salary). This is a routine governance update with no material financial impact on the company's operations or stock.

Key Facts

  • Resolution 2 (Remuneration Policy) and Resolution 21 (PSP) received less than 80% shareholder support at the 6 May 2026 AGM.
  • Company consulted with shareholders comprising ~70% of issued share capital from 18 May to 27 July 2026; only one dissenting shareholder engaged.
  • Board resolved to adopt and implement the Policy and PSP on the terms approved at the AGM.
  • CEO Deepak Nath granted a PSP top-up award of 323,728 shares at £12.744 (350% of salary, total 2026 PSP awards = 650% of salary).
  • CEO granted an RSP top-up award of 23,123 shares at £12.744 (25% of salary, total 2026 RSP awards = 150% of salary).
  • PSP award vests 15 March 2029; RSP vests in three equal tranches on 1 April 2027, 2028, and 2029.

Financial Impact

No material financial impact. CEO equity awards are routine compensation; the 346,851 total shares granted represent ~0.04% of shares outstanding, negligible dilution.

Risk Factors

  • Potential future shareholder dissent if compensation remains misaligned with performance, but no immediate risk.

Market Snapshot

Exchange
OTC
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
50% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-008075
Document: 0001654954-26-008075-index-headers.html0001654954-26-008075
Document: 0001654954-26-008075-index.html0001654954-26-008075
Document: 0001654954-26-008075.txt0001654954-26-008075
30 reports for SNN
Performance horizon
88% Hit rate 7 of 8 directional calls best @ T+20▲ +8.02%Jun 30, 2026
Filters
Rows
Reports for SNN — sortable, filterable
TypeNow
Sep 16, 2026
16d ago
6-K
NEUTRAL ★ 3/10
$27.80 $26.82▼ −3.53%▼ −6.09%$26.42 (−4.96%)
Sep 16, 2026
16d ago
6-K
NEUTRAL ★ 3/10
$27.80 $26.82▼ −3.53%▼ −6.09%$26.42 (−4.96%)
Sep 11, 2026
21d ago
6-K
NEUTRAL ★ 4/10
$27.50 $27.56▲ +0.22%▲ +0.44%$26.42 (−3.93%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 4/10
$27.62 $27.78▲ +0.58%▲ +1.08%$26.42 (−4.34%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 4/10
$27.62 $27.78▲ +0.58%▲ +1.08%$26.42 (−4.34%)
Sep 9, 2026
23d ago
6-K
NEUTRAL ★ 2/10
$27.80 $28.06▲ +0.94%▲ +1.27%$26.42 (−4.96%)
Sep 8, 2026
24d ago
424B5
NEUTRAL ★ 4/10
$27.87 $28.01▲ +0.50%▲ +1.62%$26.42 (−5.20%)
Sep 2, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.66 $27.62▼ −3.63%▼ −2.67%$26.42 (−7.82%)
Sep 2, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.66 $27.62▼ −3.63%▼ −2.67%$26.42 (−7.82%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.97 $27.80▼ −4.04%▼ −4.12%$26.42 (−8.80%)
Showing 10 of 30

US Market Status

Market Closed — Opens Mon (64h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access